These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Efficacy of norfloxacin and doxycycline for treatment of vibrio cholerae 0139 infection. Dutta D; Bhattacharya SK; Bhattacharya MK; Deb A; Deb M; Manna B; Moitra A; Mukhopadhyay AK; Nair GB J Antimicrob Chemother; 1996 Mar; 37(3):575-81. PubMed ID: 9182114 [TBL] [Abstract][Full Text] [Related]
43. The use of chlorpromazine in the treatment of cholera and other severe acute watery diarrheal diseases. Islam MR; Sack DA; Holmgren J; Bardhan PK; Rabbani GH Gastroenterology; 1982 Jun; 82(6):1335-40. PubMed ID: 7040157 [TBL] [Abstract][Full Text] [Related]
44. Efficacy and tolerability of racecadotril in the treatment of cholera in adults: a double blind, randomised, controlled clinical trial. Alam NH; Ashraf H; Khan WA; Karim MM; Fuchs GJ Gut; 2003 Oct; 52(10):1419-23. PubMed ID: 12970133 [TBL] [Abstract][Full Text] [Related]
45. Phenotypic and antibiogram pattern of V. cholerae isolates from a tertiary care hospital in Mumbai during 2004-2013: a retrospective cross-sectional study. Torane V; Kuyare S; Nataraj G; Mehta P; Dutta S; Sarkar B BMJ Open; 2016 Nov; 6(11):e012638. PubMed ID: 27888174 [TBL] [Abstract][Full Text] [Related]
46. Isolation of Vibrio cholerae from neonates admitted to an urban diarrhoeal diseases hospital in Bangladesh. Khan AM; Faruque AS; Hossain MS Ann Trop Paediatr; 2005 Sep; 25(3):179-82. PubMed ID: 16156982 [TBL] [Abstract][Full Text] [Related]
47. Tetracycline in the treatment of cholera caused by Vibrio cholerae O1 resistant to the drug in vitro. Khan AM; von Gierke U; Hossain MS; Fuchs GJ J Health Popul Nutr; 2003 Mar; 21(1):76-8. PubMed ID: 12751678 [No Abstract] [Full Text] [Related]
48. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children. Kabir I; Khan WA; Haider R; Mitra AK; Alam AN J Diarrhoeal Dis Res; 1996 Dec; 14(4):243-7. PubMed ID: 9203786 [TBL] [Abstract][Full Text] [Related]
49. Effect of massive doses of bacteriophage on excretion of vibrios, duration of diarrhoea and output of stools in acute cases of cholera. Monsur KA; Rahman MA; Huq F; Islam MN; Northrup RS; Hirschhorn N Bull World Health Organ; 1970; 42(5):723-32. PubMed ID: 4988693 [TBL] [Abstract][Full Text] [Related]
50. [Imported cholera infection caused by a new nonagglutinating cholera agent]. Emeis M; Liesenfeld O; Stephan R; Panzer-Heinig S; Stück B Dtsch Med Wochenschr; 1994 Jun; 119(24):875-8. PubMed ID: 8005066 [TBL] [Abstract][Full Text] [Related]
51. Tetracycline prophylaxis in families of cholera patients. McCormack WM; Chowdhury AM; Jahangir N; Ahmed AB; Mosley WH Bull World Health Organ; 1968; 38(5):787-92. PubMed ID: 4880663 [TBL] [Abstract][Full Text] [Related]
52. Azithromycin in the treatment of cholera in children. Bhattacharya MK; Dutta D; Ramamurthy T; Sarkar D; Singharoy A; Bhattacharya SK Acta Paediatr; 2003 Jun; 92(6):676-8. PubMed ID: 12856976 [TBL] [Abstract][Full Text] [Related]
53. Cholera incidence among patients with diarrhea visiting National Public Health Laboratory, Nepal. Karki R; Bhatta DR; Malla S; Dumre SP Jpn J Infect Dis; 2010 May; 63(3):185-7. PubMed ID: 20495270 [TBL] [Abstract][Full Text] [Related]
54. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh. Lancet; 1993 Aug; 342(8868):387-90. PubMed ID: 8101899 [TBL] [Abstract][Full Text] [Related]
55. Cholera in the Gilbert Islands. II. Clinical and laboratory findings. Roberts AB; Harris JR; Taitai T; Taraam T; Tekanene J; Cati A; Flood T; Teburae M Am J Trop Med Hyg; 1979 Jul; 28(4):685-91. PubMed ID: 464188 [TBL] [Abstract][Full Text] [Related]
56. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers. García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509 [TBL] [Abstract][Full Text] [Related]
57. Efficacy of a single dose of furazolidone for treatment of cholera in children. Rabbani GH; Butler T; Shahrier M; Mazumdar R; Islam MR Antimicrob Agents Chemother; 1991 Sep; 35(9):1864-7. PubMed ID: 1952859 [TBL] [Abstract][Full Text] [Related]
58. Efficacy of octreotide in diarrhoea due to Vibrio cholerae: a randomized, controlled trial. Abbas Z; Moid I; Khan AH; Jafri SM; Shah SH; Abid S; Hamid S Ann Trop Med Parasitol; 1996 Oct; 90(5):507-13. PubMed ID: 8915127 [TBL] [Abstract][Full Text] [Related]
59. Clinical studies of the use of bacteriophage in the treatment of cholera. Marcuk LM; Nikiforov VN; Scerbak JF; Levitov TA; Kotljarova RI; Naumsina MS; Davydov SU; Monsur KA; Rahman MA; Latif MA; Northrup RS; Cash RA; Hug I; Dey CR; Phillips RA Bull World Health Organ; 1971; 45(1):77-83. PubMed ID: 4946956 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of oral hypo-osmolar glucose-based and rice-based oral rehydration solutions in the treatment of cholera in children. Dutta D; Bhattacharya MK; Deb AK; Sarkar D; Chatterjee A; Biswas AB; Chatterjee K; Nair GB; Bhattacharya SK Acta Paediatr; 2000 Jul; 89(7):787-90. PubMed ID: 10943958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]